Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Case Reports in Oncology|December 24, 2021
Nivolumab-Induced Exocrine Pancreatic InsufficiencyBoudewijn Sweep, Sofie Wilgenhof, Sander Anten
Melanoma Research|May 16, 2012
Successful rechallenge in two patients with BRAF-V600-mutant melanoma who experienced previous progression during treatment with a selective BRAF inhibitorAmélie Clémentine Seghers, Sofie Wilgenhof, Céleste Lebbé, et al.
Cancer Investigation|October 10, 2012
Patterns of response in patients with pretreated metastatic melanoma who received ipilimumab 3 mg/kg in a European expanded access program: five illustrative case reportsSofie Wilgenhof, Stephanie Du Four, Hendrik Everaert, et al.
Virchows Archiv : an International Journal of Pathology|November 25, 2018
Adoptive cellular therapies: the current landscapeMaartje W Rohaan, Sofie Wilgenhof, John B A G Haanen
Oncoimmunology|December 18, 2012
Overcoming HLA restriction in clinical trials: Immune monitoring of mRNA-loaded DC therapyAn M T Van Nuffel, Sofie Wilgenhof, Kris Thielemans, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Single-step antigen loading and maturation of dendritic cells through mRNA electroporation of a tumor-associated antigen and a TriMix of costimulatory moleculesDaphné Benteyn, An M T Van Nuffel, Sofie Wilgenhof, et al.
Melanoma Research|October 30, 2015
Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinibYanina J Jansen, Peter Janssens, Anne Hoorens, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2012
Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studiesStephanie Du Four, Sofie Wilgenhof, Johnny Duerinck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced MelanomaSofie Wilgenhof, Jurgen Corthals, Carlo Heirman, et al.
Journal for Immunotherapy of Cancer|March 2, 2020
TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanomaBrenda De Keersmaecker, Sofie Claerhout, Javier Carrasco, et al.
Pageof 6